ORLANDO -- Most adults with type 1 diabetes switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) needed to increase their dose of the inhaled product to achieve ...

ORLANDO, Fla. — The inhaled insulin Afrezza combined with a long-acting basal analog offers a non-inferior insulin treatment option for people with type 1 diabetes, new phase 4 data suggest. Afrezza ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Among 35 adults using technosphere insulin in the INHALE ...

AID systems combine an insulin pump with a continuous glucose monitor to automatically adjust insulin levels throughout the day. Learn more about how they work.

Adults with type 1 diabetes using a continuous glucose monitoring system with a smart insulin pen attained a higher time in range if they responded more frequently to alerts for missed doses or high ...

BUFFALO, N.Y.— Treating newly diagnosed Type 1 diabetes patients with semaglutide (trade names Ozempic, Wegovy and Rybelsus) may drastically reduce or even eliminate their need for injected insulin.

A new automated insulin pump designed by Deka Research & Development and powered by Tidepool’s data and dosing platform has cleared the FDA and is now on its way to support children and adults with ...

Embecta has secured an FDA clearance for its first wearable insulin delivery system, with a patch pump designed for people with either Type 1 or Type 2 diabetes. The fully disposable device includes a ...

A drug called golimumab showed that it preserved beta-cell function in children and young adults with newly diagnosed Type 1 diabetes, according to findings from a Phase 2 study led by a UB pediatric ...

(CNN) -- A weekly dose of semaglutide, the key ingredient in blockbuster medications Ozempic and Wegovy, helped seven out of 10 patients newly diagnosed with type 1 diabetes stop taking insulin after ...